S.L. Sherwood

780 total citations · 1 hit paper
11 papers, 570 citations indexed

About

S.L. Sherwood is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Clinical Biochemistry. According to data from OpenAlex, S.L. Sherwood has authored 11 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Cellular and Molecular Neuroscience and 2 papers in Clinical Biochemistry. Recurrent topics in S.L. Sherwood's work include Epilepsy research and treatment (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and Metabolism and Genetic Disorders (2 papers). S.L. Sherwood is often cited by papers focused on Epilepsy research and treatment (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and Metabolism and Genetic Disorders (2 papers). S.L. Sherwood collaborates with scholars based in United Kingdom, United States and Tanzania. S.L. Sherwood's co-authors include W. Feldberg, John Malcolm, J. L. Tilly, W. Grey Walter, W. A. Cobb and D. A. Pond and has published in prestigious journals such as The Journal of Physiology, British Journal of Cancer and Electroencephalography and Clinical Neurophysiology.

In The Last Decade

S.L. Sherwood

9 papers receiving 437 citations

Hit Papers

Injections of drugs into ... 1954 2026 1978 2002 1954 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S.L. Sherwood United Kingdom 7 250 150 100 74 65 11 570
Gessa Gl Italy 10 257 1.0× 117 0.8× 41 0.4× 32 0.4× 71 1.1× 39 434
G. M. Everett United States 10 347 1.4× 188 1.3× 61 0.6× 25 0.3× 84 1.3× 19 702
Paul R. Draskóczy United States 13 264 1.1× 213 1.4× 64 0.6× 49 0.7× 112 1.7× 21 556
B.S.R. Sastry Canada 11 228 0.9× 174 1.2× 74 0.7× 37 0.5× 94 1.4× 14 445
N.S. Doggett United Kingdom 12 312 1.2× 176 1.2× 39 0.4× 45 0.6× 99 1.5× 36 459
G.R. Pscheidt United States 13 200 0.8× 126 0.8× 32 0.3× 26 0.4× 72 1.1× 35 476
Linda F. Quenzer United States 8 278 1.1× 169 1.1× 113 1.1× 35 0.5× 77 1.2× 12 502
Wilford L. Haslett United States 8 301 1.2× 219 1.5× 264 2.6× 171 2.3× 77 1.2× 11 666
A. Barbara Pflueger United States 15 424 1.7× 217 1.4× 51 0.5× 45 0.6× 71 1.1× 18 637
W Haefely Switzerland 15 309 1.2× 210 1.4× 141 1.4× 83 1.1× 105 1.6× 32 568

Countries citing papers authored by S.L. Sherwood

Since Specialization
Citations

This map shows the geographic impact of S.L. Sherwood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.L. Sherwood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.L. Sherwood more than expected).

Fields of papers citing papers by S.L. Sherwood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.L. Sherwood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.L. Sherwood. The network helps show where S.L. Sherwood may publish in the future.

Co-authorship network of co-authors of S.L. Sherwood

This figure shows the co-authorship network connecting the top 25 collaborators of S.L. Sherwood. A scholar is included among the top collaborators of S.L. Sherwood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.L. Sherwood. S.L. Sherwood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Tilly, J. L., et al.. (1993). Caffeine potentiates the lethality of tumour necrosis factor in cancer cells. British Journal of Cancer. 67(6). 1229–1235. 18 indexed citations
2.
Sherwood, S.L.. (1965). A theoretical consideration of perception at lower levels. Bulletin of Mathematical Biology. 27(3). 281–283.
3.
Sherwood, S.L.. (1958). Neurophysiological Data Related to Behavioural Disorders. Stereotactic and Functional Neurosurgery. 18(2-4). 315–317.
4.
Sherwood, S.L.. (1958). The EEG society. Electroencephalography and Clinical Neurophysiology. 10(2). 349–355. 1 indexed citations
5.
Pond, D. A., W. A. Cobb, W. Grey Walter, & S.L. Sherwood. (1958). The EGG society. Electroencephalography and Clinical Neurophysiology. 10(1). 198–200. 6 indexed citations
6.
Feldberg, W. & S.L. Sherwood. (1957). Effects of calcium and potassium injected into the cerebral ventricles of the cat. The Journal of Physiology. 139(3). 408–416. 50 indexed citations
7.
Feldberg, W., John Malcolm, & S.L. Sherwood. (1956). Some effects of tubocurarine on the electrical activity of the cat's brain. The Journal of Physiology. 132(1). 130–145. 28 indexed citations
8.
Feldberg, W. & S.L. Sherwood. (1955). INJECTIONS OF BULBOCAPNINE INTO THE CEREBRAL VENTRICLES OF CATS. British Journal of Pharmacology and Chemotherapy. 10(3). 371–374. 20 indexed citations
9.
Sherwood, S.L., et al.. (1954). The effect of introduction of some drugs into the cerebral ventricles on the electrical activity of the brain of cats. Electroencephalography and Clinical Neurophysiology. 6(3). 425–431. 9 indexed citations
10.
Feldberg, W. & S.L. Sherwood. (1954). Injections of drugs into the lateral ventricle of the cat. The Journal of Physiology. 123(1). 148–167. 376 indexed citations breakdown →
11.
Feldberg, W. & S.L. Sherwood. (1954). Behaviour of cats after intraventricular injections of eserine and DFP. The Journal of Physiology. 125(3). 488–500. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026